K2M, Inc., a spinal device company developing solutions for the treatment of complex spinal pathologies, and the private equity firm Welsh, Carson, Anderson & Stowe announced in a press release the closure of a transaction in which Welsh Carson has acquired the outstanding stock and become the majority shareholder of K2M.
The Welsh Carson investment will allow K2M to substantially grow its business to meet the high demand for its product portfolio by expanding its worldwide sales force and accelerating the research and development of its next generation technologies, the companies said.
“As a platform spine company, we have developed leading technologies to address the complex spine,” stated Eric Major, K2M’s president and CEO. “The closure of this strategic transaction with Welsh Carson will enable us to aggressively scale K2M in the global spine market. We are now primed to leverage the R&D efforts of the past 6 years to complete our tier one product portfolio. Our SERENGETI Minimally Invasive Retractor System, which provides direct visibility through a flexible polymer retractor, is a prime example of a crossover technology we have developed at K2M to address both complex and degenerative pathologies.”